Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

378 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study.
England JT, Szuber N, Sirhan S, Dunne T, Cerquozzi S, Hill M, Villeneuve PJA, Ho JM, Sadikovic B, Bhai P, Krishnan N, Dowhanik S, Hillis C, Capo-Chichi JM, Tsui H, Cheung V, Gauthier K, Sibai H, Davidson MB, Bankar A, Kotchetkov R, Gupta V, Maze D. England JT, et al. Among authors: davidson mb. Leukemia. 2024 Mar;38(3):570-578. doi: 10.1038/s41375-024-02155-4. Epub 2024 Feb 6. Leukemia. 2024. PMID: 38321107
Asparaginase completion among adults including older patients with acute lymphoblastic leukemia treated with a modified DFCI protocol.
Perusini MA, Andrews C, Eshetu AG, Gupta V, Maze D, Yee KWL, Bankar A, Davidson MB, Richard-Carpentier G, Chan SM, Schimmer AD, Sibai J, Alharbi S, Lucero JA, Linn SM, Minden MD, Schuh AC, Sibai H. Perusini MA, et al. Among authors: davidson mb. Leukemia. 2024 Apr;38(4):912-913. doi: 10.1038/s41375-024-02201-1. Epub 2024 Mar 2. Leukemia. 2024. PMID: 38431747 No abstract available.
Outcomes and adverse events in older acute lymphoblastic Leukemia patients treated with a pediatric-inspired protocol with Pegylated or native Asparaginase.
Perusini MA, Andrews C, Atenafu EG, Gupta V, Maze D, Schuh AC, Yee KW, Bankar A, Davidson MB, Richard-Carpentier G, Chan SM, Sibai J, Schimmer AD, Minden MD, Sibai H. Perusini MA, et al. Among authors: davidson mb. Hematology. 2024 Dec;29(1):2329027. doi: 10.1080/16078454.2024.2329027. Epub 2024 Mar 25. Hematology. 2024. PMID: 38526239
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era.
Patel AA, Yoon JJ, Johnston H, Davidson MB, Shallis RM, Chen EC, Burkart M, Oh TS, Iyer SG, Madarang E, Muthiah C, Gross I, Dean R, Kassner J, Viswabandya A, Madero-Marroquin R, Rampal RK, Guru Murthy GS, Bradley TJ, Abaza Y, Garcia JS, Gupta V, Pettit KM, Cursio JF, Odenike O. Patel AA, et al. Among authors: davidson mb. Blood Adv. 2024 May 13:bloodadvances.2024012880. doi: 10.1182/bloodadvances.2024012880. Online ahead of print. Blood Adv. 2024. PMID: 38739724
Review of Prediabetes.
Davidson MB. Davidson MB. JAMA. 2023 Aug 8;330(6):564. doi: 10.1001/jama.2023.9959. JAMA. 2023. PMID: 37552502 No abstract available.
Should Prediabetes be Treated Pharmacologically?
Davidson MB. Davidson MB. Diabetes Ther. 2023 Oct;14(10):1585-1593. doi: 10.1007/s13300-023-01449-7. Epub 2023 Jul 25. Diabetes Ther. 2023. PMID: 37490238 Free PMC article.
378 results